The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Banco Bilbao Vizcaya Argentaria S.A.

Banco Bilbao Vizcaya Argentaria S.A. lowered its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 11.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 25,096 shares of the medical device company's stock after selling 3,269 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in Cooper Companies were worth $2,308,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in Cooper Companies during the 4th quarter valued at $691,000. Highland Capital Management LLC purchased a new stake in Cooper Companies in the fourth quarter worth about $4,004,000. Caprock Group LLC purchased a new position in shares of Cooper Companies during the 4th quarter valued at $282,000. Franklin Resources Inc. raised its position in shares of Cooper Companies by 194.0% during the third quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company's stock valued at $5,265,000 after buying an additional 32,260 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its position in shares of Cooper Companies by 6.6% during the 3rd quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company's stock valued at $26,295,000 after acquiring an additional 14,687 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Cooper Companies Trading Up 1.2 %

Shares of Cooper Companies stock traded up $0.96 during trading hours on Friday, reaching $82.10. 474,413 shares of the company's stock were exchanged, compared to its average volume of 1,424,743. The company has a fifty day moving average of $81.60 and a 200-day moving average of $92.09. The Cooper Companies, Inc. has a 52-week low of $69.81 and a 52-week high of $112.38. The firm has a market capitalization of $16.42 billion, a price-to-earnings ratio of 42.09, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analysts Set New Price Targets

COO has been the topic of a number of research reports. Citigroup reduced their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. JPMorgan Chase & Co. dropped their target price on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Friday, March 7th. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Piper Sandler reaffirmed an "overweight" rating and set a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Finally, Robert W. Baird reduced their target price on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research note on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.